These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12052181)
1. Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein. Wang DY; Sen D Comb Chem High Throughput Screen; 2002 Jun; 5(4):301-12. PubMed ID: 12052181 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes. Slim G; Pritchard C; Biala E; Asseline U; Gait MJ Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380 [TBL] [Abstract][Full Text] [Related]
3. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev. Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500 [TBL] [Abstract][Full Text] [Related]
4. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. Aboul-ela F; Karn J; Varani G J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092 [TBL] [Abstract][Full Text] [Related]
5. Preparation of HIV TAR RNA with RNA scissors. Wyszko E; Fuerste JP; Barciszewska M; Szymanski M; Adamiak R; Erdmann VA; Barciszewski J J Biochem; 1999 Aug; 126(2):326-32. PubMed ID: 10423525 [TBL] [Abstract][Full Text] [Related]
6. In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1. Yamamoto R; Toyoda S; Viljanen P; Machida K; Nishikawa S; Murakami K; Taira K; Kumar PK Nucleic Acids Symp Ser; 1995; (34):145-6. PubMed ID: 8841594 [TBL] [Abstract][Full Text] [Related]
7. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA. Long KS; Crothers DM Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630 [TBL] [Abstract][Full Text] [Related]
8. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA. Bradrick TD; Marino JP RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324 [TBL] [Abstract][Full Text] [Related]
10. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Sun LQ; Wang L; Gerlach WL; Symonds G Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887 [TBL] [Abstract][Full Text] [Related]
11. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Wang S; Huber PW; Cui M; Czarnik AW; Mei HY Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455 [TBL] [Abstract][Full Text] [Related]
13. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Rana TM; Jeang KT Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810 [TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme. Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986 [TBL] [Abstract][Full Text] [Related]
17. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. Churcher MJ; Lowe AD; Gait MJ; Karn J Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280 [TBL] [Abstract][Full Text] [Related]
19. NMR evidence for a base triple in the HIV-2 TAR C-G.C+ mutant-argininamide complex. Brodsky AS; Erlacher HA; Williamson JR Nucleic Acids Res; 1998 Apr; 26(8):1991-5. PubMed ID: 9518494 [TBL] [Abstract][Full Text] [Related]
20. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]